Product Code:158002
Published Date: Jun 05,2021
Pages: 102
Region: Global
Category: Pharma & Healthcare
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
SELECT A FORMAT
ADD TO BASKET
BUY NOW
Provide comprehensive and accurate analysis and reports according to your exact requirements
According to this latest study, the 2021 growth of Anticoagulants will have significant change from previous year. By the most conservative estimates of global Anticoagulants market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 23990 million in 2020. Over the next five years the Anticoagulants market will register a 4.9% CAGR in terms of revenue, the global market size will reach US$ 29020 million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Anticoagulants market by product type, application, key players and key regions and countries. Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7. Platelet Aggregation Inhibitors (PAI) Low-Molecular-Weight Heparin (LMWH) Direct Thrombin Inhibitor (DTI) Direct Factor Xa Inhibitors (DFXa) Vitamin K antagonists (VKA) Others Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8. VTE ACS/MI AF Others This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3. Sanofi Bristol-Myers Squibb Bayer Johnson & Johnson. Genentech (Roche) Boehringer Ingelheim Lilly Daiichi Sankyo Otsuka AstraZeneca Pfizer Aspen The Medicines Company
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anticoagulants Market Size 2016-2026
2.1.2 Anticoagulants Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Anticoagulants Segment by Type
2.2.1 Platelet Aggregation Inhibitors (PAI)
2.2.2 Platelet Aggregation Inhibitors (PAI)
2.2.3 Direct Thrombin Inhibitor (DTI)
2.2.4 Direct Factor Xa Inhibitors (DFXa)
2.2.5 Vitamin K antagonists (VKA)
2.2.6 Others
2.3 Anticoagulants Market Size by Type
2.3.1 Global Anticoagulants Market Size CAGR by Type
2.3.2 Global Anticoagulants Market Size Market Share by Type (2016-2021)
2.4 Anticoagulants Segment by Application
2.4.1 VTE
2.4.2 ACS/MI
2.4.3 AF
2.4.4 Others
2.5 Anticoagulants Market Size by Application
2.5.1 Global Anticoagulants Market Size CAGR by Application
2.5.2 Global Anticoagulants Market Size Market Share by Application (2016-2021)
3 Anticoagulants Market Size by Players
3.1 Anticoagulants Market Size Market Share by Players
3.1.1 Global Anticoagulants Revenue by Players (2019-2021E)
3.1.2 Global Anticoagulants Revenue Market Share by Players (2019-2021E)
3.2 Global Anticoagulants Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Anticoagulants by Regions
4.1 Anticoagulants Market Size by Regions (2016-2021)
4.2 Americas Anticoagulants Market Size Growth (2016-2021)
4.3 APAC Anticoagulants Market Size Growth (2016-2021)
4.4 Europe Anticoagulants Market Size Growth (2016-2021)
4.5 Middle East & Africa Anticoagulants Market Size Growth (2016-2021)
5 Americas
5.1 Americas Anticoagulants Market Size by Country (2016-2021)
5.2 Americas Anticoagulants Market Size by Type (2016-2021)
5.3 Americas Anticoagulants Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anticoagulants Market Size by Region (2016-2021)
6.2 APAC Anticoagulants Market Size by Type (2016-2021)
6.3 APAC Anticoagulants Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Anticoagulants by Country (2016-2021)
7.2 Europe Anticoagulants Market Size by Type (2016-2021)
7.3 Europe Anticoagulants Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anticoagulants by Region (2016-2021)
8.2 Middle East & Africa Anticoagulants Market Size by Type (2016-2021)
8.3 Middle East & Africa Anticoagulants Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Anticoagulants Market Forecast
10.1 Global Anticoagulants Forecast by Regions (2021-2026)
10.1.1 Global Anticoagulants Forecast by Regions (2021-2026)
10.1.2 Americas Anticoagulants Forecast
10.1.3 APAC Anticoagulants Forecast
10.1.4 Europe Anticoagulants Forecast
10.1.5 Middle East & Africa Anticoagulants Forecast
10.2 Americas Anticoagulants Forecast by Countries (2021-2026)
10.2.1 United States Anticoagulants Market Forecast
10.2.2 Canada Anticoagulants Market Forecast
10.2.3 Mexico Anticoagulants Market Forecast
10.2.4 Brazil Anticoagulants Market Forecast
10.3 APAC Anticoagulants Forecast by Region (2021-2026)
10.3.1 China Anticoagulants Market Forecast
10.3.2 Japan Anticoagulants Market Forecast
10.3.3 Korea Anticoagulants Market Forecast
10.3.4 Southeast Asia Anticoagulants Market Forecast
10.3.5 India Anticoagulants Market Forecast
10.3.6 Australia Anticoagulants Market Forecast
10.4 Europe Anticoagulants Forecast by Country (2021-2026)
10.4.1 Germany Anticoagulants Market Forecast
10.4.2 France Anticoagulants Market Forecast
10.4.3 UK Anticoagulants Market Forecast
10.4.4 Italy Anticoagulants Market Forecast
10.4.5 Russia Anticoagulants Market Forecast
10.5 Middle East & Africa Anticoagulants Forecast by Region (2021-2026)
10.5.1 Egypt Anticoagulants Market Forecast
10.5.2 South Africa Anticoagulants Market Forecast
10.5.3 Israel Anticoagulants Market Forecast
10.5.4 Turkey Anticoagulants Market Forecast
10.5.5 GCC Countries Anticoagulants Market Forecast
10.6 Global Anticoagulants Forecast by Type (2021-2026)
10.7 Global Anticoagulants Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Anticoagulants Product Offered
11.1.3 Sanofi Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Information
11.2.2 Bristol-Myers Squibb Anticoagulants Product Offered
11.2.3 Bristol-Myers Squibb Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Bristol-Myers Squibb Main Business Overview
11.2.5 Bristol-Myers Squibb Latest Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Anticoagulants Product Offered
11.3.3 Bayer Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer Latest Developments
11.4 Johnson & Johnson.
11.4.1 Johnson & Johnson. Company Information
11.4.2 Johnson & Johnson. Anticoagulants Product Offered
11.4.3 Johnson & Johnson. Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Johnson & Johnson. Main Business Overview
11.4.5 Johnson & Johnson. Latest Developments
11.5 Genentech (Roche)
11.5.1 Genentech (Roche) Company Information
11.5.2 Genentech (Roche) Anticoagulants Product Offered
11.5.3 Genentech (Roche) Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Genentech (Roche) Main Business Overview
11.5.5 Genentech (Roche) Latest Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Information
11.6.2 Boehringer Ingelheim Anticoagulants Product Offered
11.6.3 Boehringer Ingelheim Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Boehringer Ingelheim Main Business Overview
11.6.5 Boehringer Ingelheim Latest Developments
11.7 Lilly
11.7.1 Lilly Company Information
11.7.2 Lilly Anticoagulants Product Offered
11.7.3 Lilly Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Lilly Main Business Overview
11.7.5 Lilly Latest Developments
11.8 Daiichi Sankyo
11.8.1 Daiichi Sankyo Company Information
11.8.2 Daiichi Sankyo Anticoagulants Product Offered
11.8.3 Daiichi Sankyo Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Daiichi Sankyo Main Business Overview
11.8.5 Daiichi Sankyo Latest Developments
11.9 Otsuka
11.9.1 Otsuka Company Information
11.9.2 Otsuka Anticoagulants Product Offered
11.9.3 Otsuka Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Otsuka Main Business Overview
11.9.5 Otsuka Latest Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Company Information
11.10.2 AstraZeneca Anticoagulants Product Offered
11.10.3 AstraZeneca Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 AstraZeneca Main Business Overview
11.10.5 AstraZeneca Latest Developments
11.11.1 Pfizer Company Information
11.11.2 Pfizer Anticoagulants Product Offered
11.11.3 Pfizer Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Pfizer Main Business Overview
11.11.5 Pfizer Latest Developments
11.12 Aspen
11.12.1 Aspen Company Information
11.12.2 Aspen Anticoagulants Product Offered
11.12.3 Aspen Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Aspen Main Business Overview
11.12.5 Aspen Latest Developments
11.13 The Medicines Company
11.13.1 The Medicines Company Company Information
11.13.2 The Medicines Company Anticoagulants Product Offered
11.13.3 The Medicines Company Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 The Medicines Company Main Business Overview
11.13.5 The Medicines Company Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Anticoagulants Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Platelet Aggregation Inhibitors (PAI) Table 3. Major Players of Low-Molecular-Weight Heparin (LMWH) Table 4. Major Players of Direct Thrombin Inhibitor (DTI) Table 5. Major Players of Direct Factor Xa Inhibitors (DFXa) Table 6. Major Players of Vitamin K antagonists (VKA) Table 7. Major Players of Others Table 8. Anticoagulants Market Size CAGR by Type (2020-2026) & ($ Millions) Table 9. Global Anticoagulants Market Size by Type (2016-2021) & ($ Millions) Table 10. Global Anticoagulants Market Size Market Share by Type (2016-2021) Table 11. Anticoagulants Market Size CAGR by Application (2016-2021) & ($ Millions) Table 12. Global Anticoagulants Market Size by Application (2016-2021) & ($ Millions) Table 13. Global Anticoagulants Market Size Market Share by Application (2016-2021) Table 14. Global Anticoagulants Revenue by Players (2019-2021E) & ($ Millions) Table 15. Global Anticoagulants Revenue Market Share by Players (2019-2021E) Table 16. Anticoagulants Key Players Head office and Products Offered Table 17. Anticoagulants Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 18. New Products and Potential Entrants Table 19. Mergers & Acquisitions, Expansion Table 20. Global Anticoagulants Market Size by Regions 2016-2021 & ($ Millions) Table 21. Global Anticoagulants Market Size Market Share by Regions 2016-2021 Table 22. Americas Anticoagulants Market Size by Country (2016-2021) & ($ Millions) Table 23. Americas Anticoagulants Market Size Market Share by Country (2016-2021) Table 24. Americas Anticoagulants Market Size by Type (2016-2021) & ($ Millions) Table 25. Americas Anticoagulants Market Size Market Share by Type (2016-2021) Table 26. Americas Anticoagulants Market Size by Application (2016-2021) & ($ Millions) Table 27. Americas Anticoagulants Market Size Market Share by Application (2016-2021) Table 28. APAC Anticoagulants Market Size by Region (2016-2021) & ($ Millions) Table 29. APAC Anticoagulants Market Size Market Share by Region (2016-2021) Table 30. APAC Anticoagulants Market Size by Type (2016-2021) & ($ Millions) Table 31. APAC Anticoagulants Market Size Market Share by Type (2016-2021) Table 32. APAC Anticoagulants Market Size by Application (2016-2021) & ($ Millions) Table 33. APAC Anticoagulants Market Size Market Share by Application (2016-2021) Table 34. Europe Anticoagulants Market Size by Country (2016-2021) & ($ Millions) Table 35. Europe Anticoagulants Market Size Market Share by Country (2016-2021) Table 36. Europe Anticoagulants Market Size by Type (2016-2021) & ($ Millions) Table 37. Europe Anticoagulants Market Size Market Share by Type (2016-2021) Table 38. Europe Anticoagulants Market Size by Application (2016-2021) & ($ Millions) Table 39. Europe Anticoagulants Market Size Market Share by Application (2016-2021) Table 40. Middle East & Africa Anticoagulants Market Size by Region (2016-2021) & ($ Millions) Table 41. Middle East & Africa Anticoagulants Market Size Market Share by Region (2016-2021) Table 42. Middle East & Africa Anticoagulants Market Size by Type (2016-2021) & ($ Millions) Table 43. Middle East & Africa Anticoagulants Market Size Market Share by Type (2016-2021) Table 44. Middle East & Africa Anticoagulants Market Size by Application (2016-2021) & ($ Millions) Table 45. Middle East & Africa Anticoagulants Market Size Market Share by Application (2016-2021) Table 46. Key and Potential Regions of Anticoagulants Table 47. Key Application and Potential Industries of Anticoagulants Table 48. Key Challenges of Anticoagulants Table 49. Key Trends of Anticoagulants Table 50. Global Anticoagulants Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 51. Global Anticoagulants Market Size Market Share Forecast by Regions (2021-2026) Table 52. Global Anticoagulants Market Size Forecast by Type (2021-2026) & ($ Millions) Table 53. Global Anticoagulants Market Size Market Share Forecast by Type (2021-2026) Table 54. Global Anticoagulants Market Size Forecast by Application (2021-2026) & ($ Millions) Table 55. Global Anticoagulants Market Size Market Share Forecast by Application (2021-2026) Table 56. Sanofi Details, Company Type, Anticoagulants Area Served and Its Competitors Table 57. Sanofi Anticoagulants Product Offered Table 58. Sanofi Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 59. Sanofi Main Business Table 60. Sanofi Latest Developments Table 61. Bristol-Myers Squibb Details, Company Type, Anticoagulants Area Served and Its Competitors Table 62. Bristol-Myers Squibb Anticoagulants Product Offered Table 63. Bristol-Myers Squibb Main Business Table 64. Bristol-Myers Squibb Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 65. Bristol-Myers Squibb Latest Developments Table 66. Bayer Details, Company Type, Anticoagulants Area Served and Its Competitors Table 67. Bayer Anticoagulants Product Offered Table 68. Bayer Main Business Table 69. Bayer Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 70. Bayer Latest Developments Table 71. Johnson & Johnson. Details, Company Type, Anticoagulants Area Served and Its Competitors Table 72. Johnson & Johnson. Anticoagulants Product Offered Table 73. Johnson & Johnson. Main Business Table 74. Johnson & Johnson. Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 75. Johnson & Johnson. Latest Developments Table 76. Genentech (Roche) Details, Company Type, Anticoagulants Area Served and Its Competitors Table 77. Genentech (Roche) Anticoagulants Product Offered Table 78. Genentech (Roche) Main Business Table 79. Genentech (Roche) Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 80. Genentech (Roche) Latest Developments Table 81. Boehringer Ingelheim Details, Company Type, Anticoagulants Area Served and Its Competitors Table 82. Boehringer Ingelheim Anticoagulants Product Offered Table 83. Boehringer Ingelheim Main Business Table 84. Boehringer Ingelheim Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 85. Boehringer Ingelheim Latest Developments Table 86. Lilly Details, Company Type, Anticoagulants Area Served and Its Competitors Table 87. Lilly Anticoagulants Product Offered Table 88. Lilly Main Business Table 89. Lilly Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 90. Lilly Latest Developments Table 91. Daiichi Sankyo Details, Company Type, Anticoagulants Area Served and Its Competitors Table 92. Daiichi Sankyo Anticoagulants Product Offered Table 93. Daiichi Sankyo Main Business Table 94. Daiichi Sankyo Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 95. Daiichi Sankyo Latest Developments Table 96. Otsuka Details, Company Type, Anticoagulants Area Served and Its Competitors Table 97. Otsuka Anticoagulants Product Offered Table 98. Otsuka Main Business Table 99. Otsuka Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 100. Otsuka Latest Developments Table 101. AstraZeneca Details, Company Type, Anticoagulants Area Served and Its Competitors Table 102. AstraZeneca Anticoagulants Product Offered Table 103. AstraZeneca Main Business Table 104. AstraZeneca Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 105. AstraZeneca Latest Developments Table 106. Pfizer Details, Company Type, Anticoagulants Area Served and Its Competitors Table 107. Pfizer Anticoagulants Product Offered Table 108. Pfizer Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 109. Pfizer Main Business Table 110. Pfizer Latest Developments Table 111. Aspen Details, Company Type, Anticoagulants Area Served and Its Competitors Table 112. Aspen Anticoagulants Product Offered Table 113. Aspen Main Business Table 114. Aspen Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 115. Aspen Latest Developments Table 116. The Medicines Company Details, Company Type, Anticoagulants Area Served and Its Competitors Table 117. The Medicines Company Anticoagulants Product Offered Table 118. The Medicines Company Main Business Table 119. The Medicines Company Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 120. The Medicines Company Latest Developments List of Figures Figure 1. Anticoagulants Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Anticoagulants Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Anticoagulants Market Size Market Share by Type in 2020 Figure 7. Anticoagulants in VTE Figure 8. Global Anticoagulants Market: VTE (2016-2021) & ($ Millions) Figure 9. Anticoagulants in ACS/MI Figure 10. Global Anticoagulants Market: ACS/MI (2016-2021) & ($ Millions) Figure 11. Anticoagulants in AF Figure 12. Global Anticoagulants Market: AF (2016-2021) & ($ Millions) Figure 13. Anticoagulants in Others Figure 14. Global Anticoagulants Market: Others (2016-2021) & ($ Millions) Figure 15. Global Anticoagulants Market Size Market Share by Application in 2020 Figure 16. Global Anticoagulants Revenue Market Share by Player in 2020 Figure 17. Global Anticoagulants Market Size Market Share by Regions (2016-2021) Figure 18. Americas Anticoagulants Market Size 2016-2021 ($ Millions) Figure 19. APAC Anticoagulants Market Size 2016-2021 ($ Millions) Figure 20. Europe Anticoagulants Market Size 2016-2021 ($ Millions) Figure 21. Middle East & Africa Anticoagulants Market Size 2016-2021 ($ Millions) Figure 22. Americas Anticoagulants Market Size Market Share by Country in 2020 Figure 23. Americas Anticoagulants Market Size Market Share by Type in 2020 Figure 24. Americas Anticoagulants Market Size Market Share by Application in 2020 Figure 25. United States Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 26. Canada Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 27. Mexico Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 28. APAC Anticoagulants Market Size Market Share by Regions in 2020 Figure 29. APAC Anticoagulants Market Size Market Share by Type in 2020 Figure 30. APAC Anticoagulants Market Size Market Share by Application in 2020 Figure 31. China Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 32. Japan Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 33. Korea Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 34. Southeast Asia Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 35. India Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 36. Australia Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 37. Europe Anticoagulants Market Size Market Share by Country in 2020 Figure 38. Europe Anticoagulants Market Size Market Share by Type in 2020 Figure 39. Europe Anticoagulants Market Size Market Share by Application in 2020 Figure 40. Germany Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 41. France Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 42. UK Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 43. Italy Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 44. Russia Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 45. Middle East & Africa Anticoagulants Market Size Market Share by Region in 2020 Figure 46. Middle East & Africa Anticoagulants Market Size Market Share by Type in 2020 Figure 47. Middle East & Africa Anticoagulants Market Size Market Share by Application in 2020 Figure 48. Egypt Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 49. South Africa Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 50. Israel Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 51. Turkey Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 52. GCC Country Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 53. Americas Anticoagulants Market Size 2021-2026 ($ Millions) Figure 54. APAC Anticoagulants Market Size 2021-2026 ($ Millions) Figure 55. Europe Anticoagulants Market Size 2021-2026 ($ Millions) Figure 56. Middle East & Africa Anticoagulants Market Size 2021-2026 ($ Millions) Figure 57. United States Anticoagulants Market Size 2021-2026 ($ Millions) Figure 58. Canada Anticoagulants Market Size 2021-2026 ($ Millions) Figure 59. Mexico Anticoagulants Market Size 2021-2026 ($ Millions) Figure 60. Brazil Anticoagulants Market Size 2021-2026 ($ Millions) Figure 61. China Anticoagulants Market Size 2021-2026 ($ Millions) Figure 62. Japan Anticoagulants Market Size 2021-2026 ($ Millions) Figure 63. Korea Anticoagulants Market Size 2021-2026 ($ Millions) Figure 64. Southeast Asia Anticoagulants Market Size 2021-2026 ($ Millions) Figure 65. India Anticoagulants Market Size 2021-2026 ($ Millions) Figure 66. Australia Anticoagulants Market Size 2021-2026 ($ Millions) Figure 67. Germany Anticoagulants Market Size 2021-2026 ($ Millions) Figure 68. France Anticoagulants Market Size 2021-2026 ($ Millions) Figure 69. UK Anticoagulants Market Size 2021-2026 ($ Millions) Figure 70. Italy Anticoagulants Market Size 2021-2026 ($ Millions) Figure 71. Russia Anticoagulants Market Size 2021-2026 ($ Millions) Figure 72. Spain Anticoagulants Market Size 2021-2026 ($ Millions) Figure 73. Egypt Anticoagulants Market Size 2021-2026 ($ Millions) Figure 74. South Africa Anticoagulants Market Size 2021-2026 ($ Millions) Figure 75. Israel Anticoagulants Market Size 2021-2026 ($ Millions) Figure 76. Turkey Anticoagulants Market Size 2021-2026 ($ Millions) Figure 77. GCC Country Anticoagulants Market Size 2021-2026 ($ Millions)
Sanofi Bristol-Myers Squibb Bayer Johnson & Johnson. Genentech (Roche) Boehringer Ingelheim Lilly Daiichi Sankyo Otsuka AstraZeneca Pfizer Aspen The Medicines Company
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives
Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights
Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis
Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape
RELATED REPORTS
Jan
2024
Global Anticoagulants Market Growth (Status and Outlook) 2024-2030
Pages: 106|Category: PHARMA & HEALTHCARE
According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period.
$3660.00